MMP9 and Alzheimer disease: Our data further revealed that HLJDD administration significantly reduced MMP-2 and MMP-9 expression in the hippocampal CA1 region of AD rats, suggesting that its neuroprotective effects may involve BBB stabilization and anti-inflammatory regulation.